Bank of New York Mellon’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $147M | Sell |
|
|||||
|
2025
Q2 | $104M | Sell |
|
|||||
|
2025
Q1 | $123M | Buy |
|
|||||
|
2024
Q4 | $141M | Sell |
|
|||||
|
2024
Q3 | $144M | Sell |
|
|||||
|
2024
Q2 | $139M | Sell |
|
|||||
|
2024
Q1 | $105M | Sell |
|
|||||
|
2023
Q4 | $122M | Sell |
|
|||||
|
2023
Q3 | $129M | Sell |
|
|||||
|
2023
Q2 | $132M | Sell |
|
|||||
|
2023
Q1 | $137M | Buy |
|
|||||
|
2022
Q4 | $161M | Sell |
|
|||||
|
2022
Q3 | $127M | Sell |
|
|||||
|
2022
Q2 | $184M | Sell |
|
|||||
|
2022
Q1 | $149M | Sell |
|
|||||
|
2021
Q4 | $219M | Buy |
|
|||||
|
2021
Q3 | $156M | Buy |
|
|||||
|
2021
Q2 | $129M | Buy |
|
|||||
|
2021
Q1 | $112M | Buy |
|
|||||
|
2020
Q4 | $76.3M | Buy |
|
|||||
|
2020
Q3 | $49M | Sell |
|
|||||
|
2020
Q2 | $59.2M | Buy |
|
|||||
|
2020
Q1 | $44.6M | Sell |
|
|||||
|
2019
Q4 | $41.7M | Sell |
|
|||||
|
2019
Q3 | $42.1M | Sell |
|
|||||
|
2019
Q2 | $43.5M | Sell |
|
|||||
|
2019
Q1 | $72.6M | Buy |
|
|||||
|
2018
Q4 | $62.2M | Sell |
|
|||||
|
2018
Q3 | $79.3M | Sell |
|
|||||
|
2018
Q2 | $75.7M | Sell |
|
|||||
|
2018
Q1 | $79.6M | Sell |
|
|||||
|
2017
Q4 | $114M | Sell |
|
|||||
|
2017
Q3 | $91.2M | Sell |
|
|||||
|
2017
Q2 | $104M | Sell |
|
|||||
|
2017
Q1 | $112M | Buy |
|
|||||
|
2016
Q4 | $111M | Buy |
|
|||||
|
2016
Q3 | $86.8M | Buy |
|
|||||
|
2016
Q2 | $67.9M | Sell |
|
|||||
|
2016
Q1 | $77.8M | Buy |
|
|||||
|
2015
Q4 | $104M | Buy |
|
|||||
|
2015
Q3 | $83.1M | Sell |
|
|||||
|
2015
Q2 | $112M | Buy |
|
|||||
|
2015
Q1 | $103M | Buy |
|
|||||
|
2014
Q4 | $69.3M | Sell |
|
|||||
|
2014
Q3 | $80M | Sell |
|
|||||
|
2014
Q2 | $79.4M | Sell |
|
|||||
|
2014
Q1 | $86.3M | Buy |
|
|||||
|
2013
Q4 | $104M | Sell |
|
|||||
|
2013
Q3 | $74.5M | Buy |
|
|||||
|
2013
Q2 | $58.7M | Buy |
|